🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Advocates: it’s your turn to register! And don’t delay - many sessions have sold out already! (Sign up for waitlist if you like one that’s full - people always cancel and you’ll automatically get in!)

Starting now! Friends of Cancer Research's webinar providing an overview of the 3 topics from the recent #Friends’ Annual Meeting 2024 and offering #advocates the opportunity to engage directly with experts. #FriendsAM24. bit.ly/3DaVx9P

Attending #SABCS24? Join the GRASP reception, one of the few opportunities for scientists, clinicians & patient advocates to connect. It's where so many collaborations are born to bring the patient experience to research! REGISTER at graspcancer.org/events/sabcs24…

Hey #bcsm, join me in congratulating Alicia C. Staley on her promotion at Medidata to CHIEF PATIENT OFFICER. We've known she was destined for great things when she created one of the strongest communities here. Can't wait to see where she will go now! 🚀🎉

In 2024, Friends’ made pivotal strides in advancing #oncology drug development, regulatory policy and promoting innovative trial designs, contributing to advancements in therapy development, evaluation, and delivery. Read Friends' 2024 Scientific Report: Bit.ly/4gCLh9u

At the Advancing the Future of Diagnostics meeting on 2/4, a panel will discuss Friends’ whitepaper on innovative validation processes for companion #diagnostictests in rare disease settings. Read the full paper before the meeting: bit.ly/4hbeuIU.

The Advancing the Future of Diagnostics and Regulatory Innovations meeting is live! Stream on YouTube now or later on-demand: youtube.com/live/wFHolEBYx…. #FriendDx

Learn more about the Session 1 findings in the digital pathology discussion document (bit.ly/3Egbqwm) and explore our Digital PATH Project research (bit.ly/3Kf4xes). #FriendsDx

At the end of the day, patients deserve high quality tests especially when the test determines the drug that will prolong their life. - Elizabeth Mansfield from Foundation Medicine #FriendDx

It was so incredible to work with such a great group of experts to align on the output of this white paper. Regulatory flexibilities for companion diagnostics with limited clinical samples are important to support patients receiving access to novel targeted therapy in oncology.

Interested in learning more about AI, diagnostics, and regulatory science as discussed in Session 3? Explore our newly launched Policy Priorities Page: friendsofcancerresearch.org/policy-priorit…. #FriendDx

PCDI the.right.dose is again collecting data on the experience of people with MBC regarding treatment, tolerability & QoL. Our latest survey focuses on those who have taken an Antibody-Drug-Conjugate (approved or in a clinical trial). 📢 Take the survey & make your voice heard!

Advocates! Friends of Cancer Research's advocate focused virtual event that provides a deeper dive into our discussions from last week's diagnostics meeting is February 19! Register today and share your questions - we'd love to answer them during the event! friendsofcancerresearch.org/event/advancin…

📍Final day (2/28/25)📍to take the PCDI (Patient-Centered Dosing Initiative) ADC survey! 🙌 @ 196 responses‼️ (goal is 200), thanks to all who’ve taken the survey!🙌 👉🏻🇺🇸 US pts w/ MBC currently/formerly on an ADC, email [email protected] for survey link! #bcsm #QoL

Looking to include more advocate partners in your work, or train as an advocate yourself? Tanja Spanic EuropaDonnaSlovenija includes this list of for places to start. #SGBCC2025

So excited to see this work published!!

Rare #cancer biomarkers make CDx validation challenging due to limited samples. Our new Drug Information Association (DIA) article proposes FDA guidance recommendations to clarify appropriate use of alternative samples—ensuring patient access to safe and effective treatments: bit.ly/3F5vP8i

Our manuscript is out! Thank you to all the researchers and advocates who contributed to this work. einpresswire.com/article/824868… Special shout out to Hillary Andrews, PhD for her leadership. npj Journals #cancerresearch

Hillary Andrews, PhD npj Journals theresa's research Absolutely excellent, such a fantastic programme. 👇🏻is Nicole Barth & my learning etc. josh-newby-2p7g.squarespace.com/marp/metarp-20… Nicole Barth